Table 5 Survival of patients according to first line chemotherapy
Median overall survival | |
|---|---|
Time in months (95% CI) | |
Cisplatin + taxanes (N = 46) | 14.2 (10.8-19.6) |
Carboplatin + taxanes (N = 69) | 10.5 (7.6-13.1) |
Platinum without taxanes (N = 28) | 11.2 (8.6-25.3) |
Other chemotherapy (N = 48) | 5.6 (4.3-8.1) |
Clinical trials testing not approved regimens (N = 7) | 5.7 (1.7 – NR) |